Non-Antiretroviral Microbicides for HIV Prevention.

作者: Yanille Scott , Charlene S Dezzutti

DOI:

关键词: Anti-Infective AgentsSexual transmissionGriffithsinVaginal microbicideVaginal floraMicrobicideMicrobicides for sexually transmitted diseasesIntensive care medicineMedicineHuman immunodeficiency virus (HIV)

摘要: Non-antiretroviral microbicide candidates were previously explored as a female-controlled method of preventing sexual transmission HIV. These products contained non-HIV specific active compounds that ultimately found to disrupt the vaginal epithelium, cause increased immune activation in female genital tract, disturb flora, and/or other irritation precluded their use microbicides. Due failure these first-generation candidates, there was shift focus developing HIV pre-exposure prophylaxis and microbicides containing small-molecule antiretrovirals. Even with limited success antiretroviral-based clinical evaluations no commercially available products, has been significant progress research. The lessons learned from previous trials have given rise more rigorous preclinical evaluation aims be better at predicting efficacy safety novel formulation delivery technologies. advances resulted renewed interest non-antiretroviral-based microbicides, such broadly neutralizing antibodies (for example, VRC01) anti-viral proteins Griffithsin), options for persons not wanting antiretroviral drugs, potential prevent multiple sexually transmitted infections.

参考文章(66)
L. C. Rohan, B. Devlin, H. Yang, Microbicide Dosage Forms Current Topics in Microbiology and Immunology. ,vol. 383, pp. 27- 54 ,(2013) , 10.1007/82_2013_357
Anne E. Burke, Kurt Barnhart, Jeffrey T. Jensen, Mitchell D. Creinin, Terri L. Walsh, Livia S. Wan, Carolyn Westhoff, Michael Thomas, David Archer, Hongsheng Wu, James Liu, William Schlaff, Bruce R. Carr, Diana Blithe, Contraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial. Obstetrics & Gynecology. ,vol. 116, pp. 1265- 1273 ,(2010) , 10.1097/AOG.0B013E3181FC3B1A
M. Camilleri, K. Madsen, R. Spiller, B. G. Van Meerveld, G. N. Verne, Intestinal barrier function in health and gastrointestinal disease Neurogastroenterology and Motility. ,vol. 24, pp. 503- 512 ,(2012) , 10.1111/J.1365-2982.2012.01921.X
John R. Mascola, Gabriela Stiegler, Thomas C. VanCott, Hermann Katinger, Calvin B. Carpenter, Chris E. Hanson, Holly Beary, Deborah Hayes, Sarah S. Frankel, Deborah L. Birx, Mark G. Lewis, Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies Nature Medicine. ,vol. 6, pp. 207- 210 ,(2000) , 10.1038/72318
Kenneth A. Feathergill, Donald P. Waller, Gustavo F. Doncel, Xaio Hui Diao, Calvin J. Chany, Morris D. Cooper, Robert A. Anderson, Lourens J.D. Zaneveld, Risa Kirkpatrick, William F. Rencher, Betsy C. Herold, Preclinical Evaluation of Sodium Cellulose Sulfate (Ushercell) as a Contraceptive Antimicrobial Agent Journal of Andrology. ,vol. 23, pp. 426- 438 ,(2002) , 10.1002/J.1939-4640.2002.TB02250.X
Zouhair Elghabi, Daniel Karcher, Fei Zhou, Stephanie Ruf, Ralph Bock, Optimization of the expression of the HIV fusion inhibitor cyanovirin-N from the tobacco plastid genome Plant Biotechnology Journal. ,vol. 9, pp. 599- 608 ,(2011) , 10.1111/J.1467-7652.2011.00598.X
Barry R. O'Keefe, Barbara Giomarelli, Dale L. Barnard, Shilpa R. Shenoy, Paul K. S. Chan, James B. McMahon, Kenneth E. Palmer, Brian W. Barnett, David K. Meyerholz, Christine L. Wohlford-Lenane, Paul B. McCray, Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae Journal of Virology. ,vol. 84, pp. 2511- 2521 ,(2010) , 10.1128/JVI.02322-09
Leigh Peterson, Kavita Nanda, Baafuor Kofi Opoku, William Kwabena Ampofo, Margaret Owusu-Amoako, Andrew Yiadom Boakye, Wes Rountree, Amanda Troxler, Rosalie Dominik, Ronald Roddy, Laneta Dorflinger, SAVVY® (C31G) Gel for Prevention of HIV infection in Women: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Ghana PLoS ONE. ,vol. 2, pp. e1312- ,(2007) , 10.1371/JOURNAL.PONE.0001312
Justin T. Clark, Meredith R. Clark, Namdev B. Shelke, Todd J. Johnson, Eric M. Smith, Andrew K. Andreasen, Joel S. Nebeker, Judit Fabian, David R. Friend, Patrick F. Kiser, Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy PLoS ONE. ,vol. 9, pp. e88509- ,(2014) , 10.1371/JOURNAL.PONE.0088509
Ann J. Hessell, Eva G. Rakasz, Pascal Poignard, Lars Hangartner, Gary Landucci, Donald N. Forthal, Wayne C. Koff, David I. Watkins, Dennis R. Burton, Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers PLOS Pathogens. ,vol. 5, ,(2009) , 10.1371/JOURNAL.PPAT.1000433